on February 3, 2003
Circulation. 2003
Published online before print February 3, 2003, doi: 10.1161/01.CIR.0000050626.25057.51
Published online before print February 3, 2003, doi: 10.1161/01.CIR.0000050626.25057.51
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 2, 2002
From the Research Institute of Public Health (R.M.S., K.N., E.P.-S., S.V., T.H.R., T.-P.T., V.-P.V., H.-M.L., M.V., J.T.S.) and Department of Public Health and General Practice (T.H.R., H.-M.L., J.T.S.), University of Kuopio, Finland; Oy Jurilab Ltd (J.K., U.R.), Kuopio, Finland; Inner Savo Health Centre (J.T.S.), Suonenjoki, Finland; and Department of Clinical Pharmacology (H.E.P.), Rigshospitalet, University of Copenhagen, Denmark. * To whom correspondence should be addressed. E-mail: jukka.salonen{at}uku.fi.
Background--Self-selected supplementation of vitamin E has been associated with reduced coronary events and atherosclerotic progression, but the evidence from clinical trials is controversial. In the first 3 years of the ASAP trial, the supplementation with 136 IU of vitamin E plus 250 mg of slow-release vitamin C twice daily slowed down the progression of carotid atherosclerosis in men but not women. This article examines the 6-year effect of supplementation on common carotid artery (CCA) intima-media thickness (IMT). Methods and Results--The subjects were 520 smoking and nonsmoking men and postmenopausal women aged 45 to 69 years with serum cholesterol Conclusions--These data replicate our 3-year findings confirming that the supplementation with combination of vitamin E and slow-release vitamin C slows down atherosclerotic progression in hypercholesterolemic persons.
Revised on November 5, 2002
Accepted on November 6, 2002
Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression. The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study
Riitta M. Salonen MD, PhD,
5.0 mmol/L (193 mg/dL), 440 (84.6%) of whom completed the study. Atherosclerotic progression was assessed ultrasonographically. In covariance analysis in both sexes, supplementation reduced the main study outcome, the slope of mean CCA-IMT, by 26% (95% CI, 5 to 46, P=0.014), in men by 33% (95% CI, 4 to 62, P=0.024) and in women by 14% (not significant). In both sexes combined, the average annual increase of the mean CCA-IMT was 0.014 mm in the unsupplemented and 0.010 mm in the supplemented group (25% treatment effect, 95% CI, 2 to 49, P=0.034). In men, this treatment effect was 37% (95 CI, 4 to 69, P=0.028). The effect was larger in subjects with either low baseline plasma vitamin C levels or CCA plaques. Vitamin E had no effect on HDL cholesterol.
Key words: arteriosclerosis • trials • ultrasonics • antioxidants • lipids
This article has been cited by other articles:
 |
|
 |
|
  Y. Dotan, I. Pinchuk, D. Lichtenberg, and M. Leshno Decision Analysis Supports the Paradigm That Indiscriminate Supplementation of Vitamin E Does More Harm than Good Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1304 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Odermarsky, J. Lykkesfeldt, and P. Liuba Poor vitamin C status is associated with increased carotid intima-media thickness, decreased microvascular function, and delayed myocardial repolarization in young patients with type 1 diabetes Am. J. Clinical Nutrition, August 1, 2009; 90(2): 447 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nambiar, S. Viswanathan, B. Zachariah, N. Hanumanthappa, and Sridhar Gopalakrishna Magadi Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials Angiology, April 1, 2009; 60(2): 221 - 234. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Vergeer, M. L. Bots, S. I. van Leuven, D. C. Basart, E. J. Sijbrands, G. W. Evans, D. E. Grobbee, F. L. Visseren, A. F. Stalenhoef, E. S. Stroes, et al. Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity: A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials Circulation, December 9, 2008; 118(24): 2515 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Sesso, J. E. Buring, W. G. Christen, T. Kurth, C. Belanger, J. MacFadyen, V. Bubes, J. E. Manson, R. J. Glynn, and J. M. Gaziano Vitamins E and C in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial JAMA, November 12, 2008; 300(18): 2123 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Pasquali and J. S. Li Prevention of Future Cardiovascular Disease in High-Risk Pediatric Patients: A Role for Lipid Lowering Therapy? Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 131 - 133. [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. De Mello Metallothionein Reverses the Harmful Effects of Angiotensin II on the Diabetic Heart J. Am. Coll. Cardiol., August 19, 2008; 52(8): 667 - 669. [Full Text] [PDF]
|
|
|
|
|
|
E. D. Peterson and T. Y. Wang The Great Debate of 2008--How Low to Go in Preventive Cardiology? JAMA, April 9, 2008; 299(14): 1718 - 1720. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Siekmeier, C. Steffen, and W. Marz Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 265 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 M. C. Houston, B. Cooil, B. J. Olafsson, and P. Raggi Juice Powder Concentrate and Systemic Blood Pressure, Progression of Coronary Artery Calcium and Antioxidant Status in Hypertensive Subjects: A Pilot Study Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, R. Tang, B. Adams-Huet, A. Harris, T. Seenivasan, J. A de Lemos, and I. Jialal Effect of high-dose {alpha}-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1392 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Leonard, J. D. Joss, D. J. Mustacich, D. H. Blatt, Y. S. Lee, and M. G. Traber Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2257 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li and H. E. Schellhorn New Developments and Novel Therapeutic Perspectives for Vitamin C J. Nutr., October 1, 2007; 137(10): 2171 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Cook, C. M. Albert, J. M. Gaziano, E. Zaharris, J. MacFadyen, E. Danielson, J. E. Buring, and J. E. Manson A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women: Results From the Women's Antioxidant Cardiovascular Study Arch Intern Med, August 13, 2007; 167(15): 1610 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis JAMA, February 28, 2007; 297(8): 842 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G Traber Heart disease and single-vitamin supplementation Am. J. Clinical Nutrition, January 1, 2007; 85(1): 293S - 299S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bleys, E. R Miller III, R. Pastor-Barriuso, L. J Appel, and E. Guallar Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 880 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fisher, K. Lees, and J. D. Spence Nutrition and Stroke Prevention Stroke, September 1, 2006; 37(9): 2430 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Crouse III Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Zhu, E. Daghini, A. R. Chade, M. Rodriguez-Porcel, C. Napoli, A. Lerman, and L. O. Lerman Role of Oxidative Stress in Remodeling of the Myocardial Microcirculation in Hypertension Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1746 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Q Pham and R. Plakogiannis Vitamin E Supplementation in Cardiovascular Disease and Cancer Prevention: Part 1 Ann. Pharmacother., November 1, 2005; 39(11): 1870 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Miller III, L. J. Appel, E. Guallar, and R. Pastor-Barriuso High-Dosage Vitamin E Supplementation and All-Cause Mortality Ann Intern Med, July 19, 2005; 143(2): 156 - 158. [Full Text] [PDF]
|
|
|
|
|
|
J. H.K. Vogel, S. F. Bolling, R. B. Costello, E. M. Guarneri, M. W. Krucoff, J. C. Longhurst, B. Olshansky, K. R. Pelletier, C. M. Tracy, R. A. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) J. Am. Coll. Cardiol., July 5, 2005; 46(1): 184 - 221. [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Szmitko and S. Verma Antiatherogenic potential of red wine: clinician update Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2023 - H2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N Hathcock, A. Azzi, J. Blumberg, T. Bray, A. Dickinson, B. Frei, I. Jialal, C. S Johnston, F. J Kelly, K. Kraemer, et al. Vitamins E and C are safe across a broad range of intakes Am. J. Clinical Nutrition, April 1, 2005; 81(4): 736 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Jialal and S. Devaraj Scientific Evidence to Support a Vitamin E and Heart Disease Health Claim: Research Needs J. Nutr., February 1, 2005; 135(2): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Madamanchi, A. Vendrov, and M. S. Runge Oxidative Stress and Vascular Disease Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kato, T. Takita, Y. Maruyama, and A. Hishida Chlamydial infection and progression of carotid atherosclerosis in patients on regular haemodialysis Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2539 - 2546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. M. Raijmakers, R. Dechend, and L. Poston Oxidative Stress and Preeclampsia: Rationale for Antioxidant Clinical Trials Hypertension, October 1, 2004; 44(4): 374 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Magyar, G. Paragh, E. Katona, A. Valikovics, I. Seres, L. Csiba, and D. Bereczki Serum Cholesterols Have a More Important Role Than Triglycerides in Determining Intima-Media Thickness of the Common Carotid Artery in Subjects Younger Than 55 Years of Age J. Ultrasound Med., September 1, 2004; 23(9): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zureik, P. Galan, S. Bertrais, L. Mennen, S. Czernichow, J. Blacher, P. Ducimetiere, and S. Hercberg Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1485 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden Consequences of Diabetes: Cardiovascular disease Diabetes Care, July 1, 2004; 27(7): 1825 - 1831. [Full Text] [PDF]
|
|
|
|
 |
|
 F Violi, L Loffredo, L Musella, and A Marcoccia Should antioxidant status be considered in interventional trials with antioxidants? Heart, June 1, 2004; 90(6): 598 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Zhu, M. Rodriguez-Porcel, M. D. Bentley, A. R. Chade, V. Sica, C. Napoli, N. Caplice, E. L. Ritman, A. Lerman, and L. O. Lerman Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia Circulation, May 4, 2004; 109(17): 2109 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Monzani, N. Caraccio, M. Kozakowa, A. Dardano, F. Vittone, A. Virdis, S. Taddei, C. Palombo, and E. Ferrannini Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled Study J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2099 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rodriguez-Porcel, J. Herrman, A. R. Chade, J. D. Krier, J. F. Breen, A. Lerman, and L. O. Lerman Long-Term Antioxidant Intervention Improves Myocardial Microvascular Function in Experimental Hypertension Hypertension, February 1, 2004; 43(2): 493 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Micheletta, S. Natoli, M. Misuraca, E. Sbarigia, U. Diczfalusy, and L. Iuliano Vitamin E Supplementation in Patients With Carotid Atherosclerosis: Reversal of Altered Oxidative Stress Status in Plasma but not in Plaque Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 136 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Wang, T.-M. Hung, J. Wei, and A.-N. Chiang Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice Cardiovasc Res, January 1, 2004; 61(1): 169 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mehta, B. Hu, J. Chen, and D. Li Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2203 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Griendling and G. A. FitzGerald Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies Circulation, October 28, 2003; 108(17): 2034 - 2040. [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Earnest, K. A. Wood, and T. S. Church Complex Multivitamin Supplementation Improves Homocysteine and Resistance to LDL-C Oxidation J. Am. Coll. Nutr., October 1, 2003; 22(5): 400 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Chade, M. Rodriguez-Porcel, J. Herrmann, J. D. Krier, X. Zhu, A. Lerman, and L. O. Lerman Beneficial Effects of Antioxidant Vitamins on the Stenotic Kidney Hypertension, October 1, 2003; 42(4): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Qin, J. Shite, and C.-s. Liang Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G Harrison, Hua Cai, U. Landmesser, and K. K Griendling The Pickering Lecture British Hypertension Society, 10th September 2002: Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 51 - 61. [Abstract] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Inflammation and Insulin Resistance Diabetes Care, June 1, 2003; 26(6): 1922 - 1926. [Full Text] [PDF]
|
|
|
|
|
|
I. Jialal and S. Devaraj Antioxidants and Atherosclerosis: Don't Throw Out the Baby With the Bath Water Circulation, February 25, 2003; 107(7): 926 - 928. [Full Text] [PDF]
|
|